Emcure Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹2,469.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.49 per cent from ₹2,363.48 crore. This corresponds to a year-on-year *(YoY) growth of 16.70 per cent.
Operating Profit
Operating Profit stands at ₹479.55 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.49 per cent from ₹454.60 crore. This corresponds to a year-on-year *(YoY) growth of 22.32 per cent.
PBDT
PBDT stands at ₹447.44 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.92 per cent from ₹418.47 crore. This corresponds to a year-on-year *(YoY) growth of 25.18 per cent.
Profit Before Tax
Profit Before Tax stands at ₹341.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.73 per cent from ₹313.79 crore. This corresponds to a year-on-year *(YoY) growth of 30.91 per cent.
Net Profit
Net Profit stands at ₹243.73 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.34 per cent from ₹231.37 crore. This represents a 23.57 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Emcure Pharmaceuticals Ltd News
Emcure Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Emcure Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Emcure Pharmaceuticals Ltd Research Reports
Emcure Pharmaceuticals Ltd Financial Reports
Emcure Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Emcure Pharma | -1.12% | -1.83% | -4.49% | 17.92% | 19.10% | 26.33% |
| Ajanta Pharma | -3.55% | -5.36% | 0.44% | -1.61% | 13.91% | 14.20% |
| J B Chemicals & | -1.35% | -2.43% | 4.52% | 4.69% | 22.84% | 28.65% |
| Wockhardt | 14.62% | 23.87% | 42.46% | 55.02% | 38.06% | 38.58% |
| Acutaas Chemical | 4.52% | 7.45% | 17.29% | 43.19% | 77.13% | 179.27% |
| Sai Life | 2.52% | -1.60% | 7.06% | 16.39% | 32.72% | 60.05% |
| Piramal Pharma | -1.03% | -3.88% | 7.55% | 12.72% | -6.71% | -16.15% |
Company Info
Company Information
Whole Time Director : MUKUND KESHAO GURJAR
Whole Time Director : SUNIL RAJNIKANT MEHTA
Managing Director & Chief Executive Officer : SATISH RAMANLAL MEHTA
Chairman (Non-Executive) : Berjis M Desai
Whole Time Director : NAMITA VIKAS THAPAR
Independent Director : P S Jayakumar
Independent Director : Vijay Gokhale
Independent Director : Vidya Rajiv Yeravdekar
Independent Director : Shailesh Ayyangar
Whole-time Director : SAMIT SATISH MEHTA
Company Sec. & Compli. Officer : Amruta Jana Yangalwar